The Abu Dhabi Investment Authority (ADIA), one of the world’s largest sovereign wealth funds, has made a significant investment in Hologic, a global medical technology firm focused on women’s health. The investment is part of a major deal led by private equity giants Blackstone and TPG to take Hologic private.
Quick Facts
- ADIA acquired a minority stake in Hologic.
- The deal takes Hologic private via Blackstone and TPG.
- Total deal value is up to $79 per share.
A Strategic Play in Global Health Tech
The transaction, which has now been completed following shareholder and regulatory approvals, sees ADIA participating through a wholly-owned subsidiary. Singapore’s sovereign fund, GIC, also took part in the investment, highlighting continued interest from major state-backed funds in the international health technology sector.
This move underscores a growing trend of Gulf-based sovereign wealth funds deploying capital into pioneering companies in specialized therapeutic and medical innovation sectors globally. By joining forces with established players like Blackstone and TPG, ADIA secures a position in a leading women’s health firm.
Unpacking the Deal Structure
Under the terms of the agreement, Hologic shareholders will receive $76 in cash for each share they hold.
The deal also includes a contingent value right, offering an additional payment of up to $3 per share. This extra payout is tied to specific future revenue targets for Hologic’s breast health division for the fiscal years 2026 and 2027, creating a performance-based incentive for investors.
ADIA’s Diversification Strategy
For ADIA, this investment aligns with its long-term strategy of diversifying its vast international portfolio. The fund has steadily built a notable presence in major global healthcare deals over the past few years, often through strategic partnerships with other large-scale investment institutions.
The stake in Hologic strengthens ADIA’s exposure to the advanced medical technologies field, adding a key asset in a high-growth and resilient industry to its holdings.
About Hologic
Hologic is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. The company’s core business segments include diagnostics, breast and skeletal health, GYN surgical, and medical aesthetics.
Source: Jawlah
